ArticleFrontiers in oncology2020

Development and External Validation of a Nomogram to Predict Recurrence-Free Survival After R0 Resection for Stage II/III Gastric Cancer: An International Multicenter Study.

Jun Lu et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.